Related references
Note: Only part of the references are listed.Second and third line treatment in non-small cell lung cancer
Adolfo Favaretto et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non-Small-Cell Lung Cancer
Egbert F. Smit et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer
Keun-Wook Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma - A southwest oncology group study
UN Vaishampayan et al.
CANCER (2005)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phase II study of paclitaxel and carboplatin in advanced gastric cancer previously treated with 5-fluorouracil and platinum
HM Chang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase II study of docetaxel and carboplatin as second-line treatment in NSCLC
FM Wachters et al.
LUNG CANCER (2004)
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
M Taron et al.
HUMAN MOLECULAR GENETICS (2004)
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: A feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma
LC Pagliaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancer
E Laack et al.
LUNG CANCER (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer
M Oka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Share Paper
